Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven H. Liang, Ph.D.

Title
Institution
Department
Address
Profile Picture

Overview

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01MH117125 (LIANG, STEVEN HUAN) Jul 1, 2018 - Mar 31, 2021
    NIH/NIMH
    PET ligand development for mGlu2 based on negative allosteric modulators
    Role: Principal Investigator
  2. R21DA043507 (LIANG, STEVEN HUAN) Jul 1, 2017 - Jun 30, 2019
    NIH/NIDA
    Novel PET Tracers for Imaging Monoacylglycerol Lipase in Endocannabinoid Signaling
    Role: Principal Investigator
  3. K01DA038000 (LIANG, STEVEN HUAN) Jul 1, 2014 - Jun 30, 2019
    NIH/NIDA
    New PET tracers for neuroimaging of FAAH in endocannabinoid signaling
    Role: Principal Investigator
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Liang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (209)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.